Navigation Links
SOCMA President to Lead ChemOutsourcing Keynote Panel on API Supply Base on Wednesday, September 15 at New Jersey Show
Date:9/13/2010

LONG BRANCH, N.J., Sept. 13 /PRNewswire/ -- SOCMA President & CEO Lawrence Sloan will lead the keynote panel discussion at the annual ChemOutsourcing conference this coming Wednesday morning. The panel will address the "Shifting Landscape of the API Supply Base" to explore the evolving API supply chain, reports Mark Alexay, the organizer.

Sloan's opening remarks will touch on current global supply chain topics and SOCMA's Bulk Drug Pharmaceutical Task Force. The BPTF was set up to address supply chain concerns and provide information to the FDA and Congress on related issues. The discussion will then be opened up to the speakers.

The panel discussion is organized around the following topics:

  • Legislative & Regulatory Activity
  • Strategies to Better Safeguard API Sourcing
  • Future of API Sourcing

  • The panel is comprised of the following participants:M. Bhupathy, Ph.D.Executive Director, Chemistry R & D OutsourcingAmgen Michael EakinsPrincipal ConsultantEakins & Associates Elut HsuVP Business DevelopmentAsymchem LaboratoriesNeil SawantAssociate Director, Development Strategic SourcingNovartis Michael SemoConsultant, Virtual CMC TeamEli Lilly Stuart SilvermanPharmaceutical Business DevelopmentPfizerPress and other contacts may reach ChemOutsourcing organizer Mark Alexay at info@chemoutsourcing.com, 201 452 4023

    ChemOutsourcing is an annual chemical sourcing and ingredients conference & exhibition focused on the pharmaceutical, small molecule biotech, and chemical industries. It takes places in September in New Jersey. The international event is attended primarily by 750-1000 industrial chemists. ChemOutsourcing 2010 will take place from September 13-16 at Ocean Place Resort in Long Branch, NJ. Additional information is available at www.chemoutsourcing.com.


    '/>"/>
    SOURCE ChemOutsourcing
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1

    Related biology technology :

    1. Medicago named in Presidential report on meeting the challenges of pandemic influenza
    2. PharmaNet Development Group Appoints Anthony Maida, Vice President, Clinical Research
    3. Verenium Appoints Kevin Bracken Vice President of Manufacturing
    4. Scott & White Healthcare President and CEO Alfred B. Knight, M.D. to Retire in 2011, Will Lead Foundation
    5. Sigma-Aldrich Announces Appointment of Magnus Borg as Vice President and Chief Information Officer (CIO)
    6. Adeona Appoints Julie A. Caudill, B.B.A., Vice President of Finance and Corporate Controller
    7. Chimerix Appoints Two New Vice Presidents to Clinical Management Team
    8. SemBioSys Appoints President of US and International Operations and Announces the Appointments of Three Vice Presidents
    9. Lafmin Morgan Joins Talecris Biotherapeutics as Vice President, U.S. Product Management
    10. Michael Garippa Joins SynCardia as President
    11. New President and CEO appointed at Ocean Nutrition Canada Limited
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:3/28/2017)... Calif. , March 28, 2017 ... of international life sciences corporation Anpac Bio-Medical ... set a new, international record, processing and reporting ... "Cancer Differentiation Analysis" (CDA) liquid biopsy ... World Nobel Prize Laureate Summit publications, Anpac Bio,s ...
    (Date:3/28/2017)... ... 2017 , ... LabKey and collaborator Just Biotherapeutics, Inc. (Just) ... LabKey Biologics . Built in collaboration with Just and designed with input from ... research teams tools for biological entity registration, assay data integration, and workflow management ...
    (Date:3/28/2017)... , March 28, 2017 ... volatile and unpredictable sector due to the scientifically ... served include medical, agricultural, environmental, and industrial. In today,s ... stocks: Portola Pharmaceuticals Inc. (NASDAQ: PTLA), OvaScience Inc. ... Ocular Therapeutix Inc. (NASDAQ: OCUL ). ...
    (Date:3/28/2017)... 2017 /PRNewswire/ -RepliCel Life Sciences Inc. (OTCQB: REPCF) (TSXV: RP) ... safety and clinical data from its phase 1/2 tendon repair ... follicle-derived fibroblasts (RCT-01) as a treatment for Achilles tendinosis. ... The ... profile at 6 months and showed no serious adverse events ...
    Breaking Biology Technology:
    (Date:3/9/2017)... VIEW, Calif. , March 9, 2017 ... 23andMe , the leading personal genetics company, are using ... now provide customers with personalized nutrition plans that consider ... but also genetic markers impacting how their body may ... food decision support platform uses biometrics such as Body ...
    (Date:3/2/2017)... Summary This report provides all ... and its partnering interests and activities since 2010. ... The Partnering Deals and Alliance since 2010 report provides ... of the world,s leading life sciences companies. ... ensure inclusion of the most up to date deal ...
    (Date:2/28/2017)... Germany , February 28, 2017 News ... ... Amsterdam from 14 to 16 March, Materna ... destination, and show how seamless travel is a real benefit for ... has added biometrics to their passenger touch point solutions to take ...
    Breaking Biology News(10 mins):